| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.29 | 3e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.29 | 4e-08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |